Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
DI ›
DIFICIN
Trademark search for:
DIFICIN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-07-16 — Application filed
2008-07-21 — Application filed
2008-07-22 — Notice of pseudo mark mailed
2008-10-24 — Final disposition recorded
2008-10-24 — Final disposition recorded
2008-10-24 — Assigned to examiner
2008-10-24 — Final disposition recorded
2009-04-22 — Office action issued
2009-04-22 — Assigned to lie
2009-04-23 — Approved for pub - principal register
2009-04-23 — Teas/email correspondence entered
2009-04-23 — Assigned to lie
2009-04-23 — Correspondence received in law office
2009-04-23 — Law office publication review completed
2009-05-06 — Notice of publication
2009-05-26 — Published for opposition
2009-07-10 — Teas post publication amendment received
2009-08-04 — Assigned to petition staff
2009-08-07 — Post publication amendment - entered
2009-08-18 — Noa mailed - sou required from applicant
2010-02-02 — Sou teas extension received
2010-02-02 — Sou extension 1 filed
2010-02-02 — Sou extension 1 granted
2010-08-10 — Sou teas extension received
2010-08-10 — Sou extension 2 filed
2010-08-31 — Case assigned to intent to use paralegal
2010-08-31 — Sou extension 2 granted
2010-09-01 — Notice of approval of extension request e-mailed
2011-01-31 — Sou teas extension received
2011-01-31 — Sou extension 3 filed
2011-02-02 — Sou extension 3 granted
2011-02-03 — Notice of approval of extension request e-mailed
2011-03-07 — Application abandoned
2011-03-08 — Application abandoned
2011-03-08 — Application abandoned
2011-03-08 — Final status recorded
Owner Information
Optimer Pharmaceuticals, Inc.
Optimer Pharmaceuticals
Correspondent
KENT H. CHENG COHEN PONTANI LIEBERMAN & PAVANE LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
